Journal Article

Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via α-hydroxylation and carbonyl reduction pathways

Bogdan Prokopczyk, Neil Trushin, Joanna Leszczynska, Steven E. Waggoner and Karam El-Bayoumy

in Carcinogenesis

Volume 22, issue 1, pages 107-114
Published in print January 2001 | ISSN: 0143-3334
Published online January 2001 | e-ISSN: 1460-2180 | DOI:
Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via α-hydroxylation and carbonyl reduction pathways

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics


Show Summary Details


We determined the ability of human epithelial cervical cells, human cervical microsomes and cytosol to metabolize 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). All preparations metabolized NNK by α-hydroxylation, demonstrated by the presence of 4-oxo-4-(3-pyridyl)butyric acid (keto acid), and by carbonyl reduction, illustrated by the formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL). Cervical cells metabolized NNK by the oxidative pathway to an extent comparable to that by the reductive pathway. In both human cervical cytosol and microsomes, the concentration of α-hydroxylation products ranged from undetectable to 10 times lower than those of NNAL. An apparent Km and Vmax of 7075 μM and 650 pmol/mg/min, respectively, were determined for the keto acid in one microsomal preparation. NNAL was formed in all preparations at the highest levels, ranging from 16.9 to 35.5 pmol/106 cells in incubations with ectocervical cells and 6.2 pmol/106 cells in incubations with endocervical cells. NNAL levels were 1.88–4.95 and 1.44–2.08 pmol/mg/min in human cervical microsomes and cytosolic fractions, respectively. An apparent Km of 739 μM and a Vmax of 1395 pmol/mg/min for NNAL formation were established in the same microsomal preparation used for the keto acid kinetics study. The stereochemistry of the NNAL formed in incubations of NNK with human cervical cells and subcellular fractions was determined by derivatization with (S)-(–)-methylbenzyl isocyanate. Human cervical cells and microsomes both formed the (R)-enantiomer of NNAL almost exclusively; incubations with human cervical cytosol resulted predominantly in the formation of the (S)-enantiomer. Substrates for 11β-hydroxysteroid dehydrogenase, cortisone, glycyrrhizic acid and metyrapone all inhibited the formation of NNAL in incubations with human cervical microsomes; the inhibition ranged from 16% to 80%. These studies illustrate that human cervical tissue can metabolize NNK by both oxidative and reductive pathways and that 11β-HSD may, in part, be responsible for the carbonyl reduction of NNK.

Keywords: COX, cyclooxygenase; DTT, dithiothreitol; EDTA, ethylenediaminetetraacetic acid; HPLC, high performance liquid chromatography; 11β-HSD, 11β-hydroxysteroid dehydrogenase; keto alcohol, 4-hydroxy-1-(3-pyridyl)-1-butanone; keto acid, 4-oxo-4-(3-pyridyl)butyric acid; KGM, keratinocyte growth medium; LOX, lipoxygenase; NNAL, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; P450, cytochrome P450; PBS, phosphate-buffered saline; PMSF, phenylmethylsulfonyl fluoride; (S)-MBIC, (S)-(–)-methylbenzyl isocyanate.

Journal Article.  6574 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.